Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Other Non-Current Liabilities came in at $768951.0 in Q1 2026, up 60.39% year-on-year from $479421.0 in Q1 2025, and down 93.85% quarter-over-quarter from $12.5 million in Q4 2025.
Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $768951.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 60.39% year-over-year to $768951.0 in Q1 2026; TTM through Mar 2026 was $768951.0, a 60.39% increase from a year earlier, with the FY2025 full-year figure at $12.5 million, up 149.73% from the prior year.
- Other Non-Current Liabilities fell to $768951.0 in Q1 2026 per GRUSF's latest filing, from $12.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $657.6 billion in Q3 2025 and bottomed at $193195.5 in Q4 2024.
- The 4-year median for Other Non-Current Liabilities is $768951.0 (2026), against an average of $93.9 billion.
- Across the five-year window, Other Non-Current Liabilities slumped 97.42% in 2024 and soared 6372.29% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $7.5 million in 2023, then slumped by 97.42% to $193195.5 in 2024, then soared by 6372.29% to $12.5 million in 2025, then sank by 93.85% to $768951.0 in 2026.
- Per Business Quant, the three latest GRUSF Other Non-Current Liabilities figures stand at $768951.0 (Q1 2026), $12.5 million (Q4 2025), and $657.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 768,951.00 |
| Dec 31, 2025 | 12.50 Mn |
| Sep 30, 2025 | 657.63 Bn |
| Jun 30, 2025 | 657,627.00 |
| Mar 31, 2025 | 479,421.00 |
| Dec 31, 2024 | 193,195.51 |
| Dec 31, 2023 | 7.48 Mn |
| Aug 31, 2018 | 572,717.53 |
| May 31, 2018 | 583,997.90 |
| Feb 28, 2018 | 595,244.05 |
| Nov 30, 2017 | 597,802.38 |
| Aug 31, 2017 | 582,211.56 |
| May 31, 2017 | 2.19 Mn |
| Feb 28, 2017 | 2.23 Mn |
| Nov 30, 2016 | 2.22 Mn |
| Aug 31, 2016 | 2.26 Mn |
| May 31, 2016 | 3.40 Mn |
| Feb 29, 2016 | -3.42 Mn |
| Nov 30, 2015 | 8,760.24 |
| Aug 31, 2015 | -105,816.17 |